IMFINZI® Consolidation - for Locally Advanced Non Small Cell Lung Cancer
IMFINZI® (Durvalumab) consolidation treatment - for Stage III Non Small Cell Lung Cancer
Treatment started after completion of chemoradiation if disease has not progressed. Monitor closely for immune mediated end organ damage such as Pneumonitis, Colitis, Hepatitis, Endocrinopathies and Nephritis.
Drug Mode Given Standard Dose Days to Be Given Frequency Solution Volume Duration
IMFINZI® (Durvalumab) IV 10 mg/kg D1 q14 NSS 250 cc 60 minutes